THU299 Safety Of Immune Checkpoint Inhibitor Cancer Therapy In Patients With Pre-existing Type 1 Diabetes Mellitus: A Multi-Center Cohort Study

Disclosure: R. Hilder: None. T. Karen: None. D. Isaacs: None. A. Drakaki: None. M.G. Lechner: None. Introduction: Immune checkpoint inhibitors have revolutionized cancer therapy, producing dramatic tumor shrinkage and durable responses in many advanced malignancies. A limitation of their use is the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hilder, Robin, Karen, Tsai, Isaacs, Dayna, Drakaki, Alexandra, Lechner, Melissa G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Diabetes And Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555663/
http://dx.doi.org/10.1210/jendso/bvad114.734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10555663/
http://dx.doi.org/10.1210/jendso/bvad114.734

Ejemplares similares